These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 16158952

  • 1. Effect of chemotherapy on the mutation frequency of ovarian cancer cells at the HPRT locus.
    Gercel-Taylor C, Scobee JJ, Taylor DD.
    Anticancer Res; 2005; 25(3B):2113-7. PubMed ID: 16158952
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inhibitory effect of genistein and daidzein on ovarian cancer cell growth.
    Gercel-Taylor C, Feitelson AK, Taylor DD.
    Anticancer Res; 2004; 24(2B):795-800. PubMed ID: 15161029
    [Abstract] [Full Text] [Related]

  • 6. [Chemosensitivity testing of topotecan as second-line agent in chemotherapy of ovarian cancer].
    Qian XL, Peng ZL, Liu SL.
    Ai Zheng; 2003 Dec; 22(12):1352-4. PubMed ID: 14693068
    [Abstract] [Full Text] [Related]

  • 7. Anticancer drugs induce mdr1 gene expression in recurrent ovarian cancer.
    Hille S, Rein DT, Riffelmann M, Neumann R, Sartorius J, Pfützner A, Kurbacher CM, Schöndorf T, Breidenbach M.
    Anticancer Drugs; 2006 Oct; 17(9):1041-4. PubMed ID: 17001177
    [Abstract] [Full Text] [Related]

  • 8. Comparative evaluation of the treatment efficacy of suberoylanilide hydroxamic acid (SAHA) and paclitaxel in ovarian cancer cell lines and primary ovarian cancer cells from patients.
    Sonnemann J, Gänge J, Pilz S, Stötzer C, Ohlinger R, Belau A, Lorenz G, Beck JF.
    BMC Cancer; 2006 Jul 11; 6():183. PubMed ID: 16834771
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Absence of Bcl-xL down-regulation in response to cisplatin is associated with chemoresistance in ovarian carcinoma cells.
    Villedieu M, Louis MH, Dutoit S, Brotin E, Lincet H, Duigou F, Staedel C, Gauduchon P, Poulain L.
    Gynecol Oncol; 2007 Apr 11; 105(1):31-44. PubMed ID: 17275076
    [Abstract] [Full Text] [Related]

  • 16. Increased frequency of specific locus mutation following human cytomegalovirus infection.
    Albrecht T, Fons MP, Deng CZ, Boldogh I.
    Virology; 1997 Mar 31; 230(1):48-61. PubMed ID: 9126261
    [Abstract] [Full Text] [Related]

  • 17. Topotecan versus treosulfan, an alkylating agent, in patients with epithelial ovarian cancer and relapse within 12 months following 1st-line platinum/paclitaxel chemotherapy. A prospectively randomized phase III trial by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR).
    Meier W, du Bois A, Reuss A, Kuhn W, Olbricht S, Gropp M, Richter B, Lück HJ, Kimmig R, Pfisterer J.
    Gynecol Oncol; 2009 Aug 31; 114(2):199-205. PubMed ID: 19446314
    [Abstract] [Full Text] [Related]

  • 18. Effect of folate deficiency on mutations at the hprt locus in Chinese hamster ovary cells exposed to monofunctional alkylating agents.
    Branda RF, Lafayette AR, O'Neill JP, Nicklas JA.
    Cancer Res; 1997 Jul 01; 57(13):2586-8. PubMed ID: 9205059
    [Abstract] [Full Text] [Related]

  • 19. Advanced ovarian cancer: a clinical update on first-line treatment, recurrent disease, and new agents.
    Ozols RF.
    J Natl Compr Canc Netw; 2004 Sep 01; 2 Suppl 2():S60-73. PubMed ID: 19780247
    [Abstract] [Full Text] [Related]

  • 20. Non-cytotoxic and sublethal paclitaxel treatment potentiates the sensitivity of cultured ovarian tumor SKOV-3 cells to lysis by lymphokine-activated killer cells.
    Law KS, Chen HC, Liao SK.
    Anticancer Res; 2007 Sep 01; 27(2):841-50. PubMed ID: 17465210
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.